Balancing Benefits and Risks of Rituximab in Pediatric Idiopathic Nephrotic Syndrome: The Critical Role of Age.

Kidney Int Rep · 2026 · PMC13200033 · PMID 42199212

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = 0.07so close (0.05 < p ≤ 0.1)

Increasing age showed a trend toward reduced relapse risk (adjusted hazard ratio: 0.76/yr; 95% CI: 0.57–1.03; P = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.